Caplin Point Laboratories Ltd Stock NSE India S.E.
Stocks
INE475E01018
Pharmaceuticals
|
End-of-day quote
NSE India S.E.
|
||
| - INR | - |
|
| 08-14 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 08-12 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 214B 2.26B 1.94B 1.83B 1.67B 3.12B 3.13B 21.69B 8.38B 110B 8.49B 8.31B 349B | P/E 2027 * |
29.4x | P/E 2028 * | 25.4x |
|---|---|---|---|---|---|
| Enterprise Value | 214B 2.26B 1.94B 1.83B 1.67B 3.12B 3.13B 21.69B 8.38B 110B 8.49B 8.31B 349B | EV / Sales 2027 * |
8.53x | EV / Sales 2028 * | 7.55x |
| Free-Float |
26.56% | Yield 2027 * |
0.14% | Yield 2028 * | 0.14% |
Last Transcript : Caplin Point Laboratories Ltd
| Manager | Title | Age | Since |
|---|---|---|---|
Sridhar Ganesan
CEO | Chief Executive Officer | 71 | 2015-03-27 |
D. Muralidharan
DFI | Director of Finance/CFO | - | 2016-02-18 |
Anto V.
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2010-01-26 | |
| Director/Board Member | - | 2025-11-04 | |
Sridhar Ganesan
BRD | Director/Board Member | 71 | 2015-03-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.21% | -4.52% | +18.91% | +67.25% | 48.26B | |
| +0.38% | -4.88% | +39.02% | +117.72% | 40.5B | |
| +0.72% | -1.01% | -10.20% | +11.66% | 11.85B | |
| +3.29% | -0.38% | +14.11% | +82.76% | 11.83B | |
| -1.50% | -0.38% | +24.76% | +138.18% | 9.36B | |
| -0.86% | -3.20% | +23.76% | +38.38% | 7.5B | |
| -0.52% | -3.14% | +35.52% | -14.02% | 7.37B | |
| +0.60% | -1.13% | +19.49% | +208.86% | 7.28B | |
| -0.32% | -1.85% | -46.31% | +22.01% | 5.19B | |
| Average | +0.19% | -2.35% | +13.23% | +74.76% | 16.57B | |
| Weighted average by Cap. | +0.24% | -1.85% | +20.87% | +82.09% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 25.07B 265M 228M 214M 196M 366M 367M 2.54B 983M 12.84B 996M 974M 40.9B | 28.34B 300M 258M 242M 221M 414M 415M 2.87B 1.11B 14.51B 1.13B 1.1B 46.23B |
| Net income | 7.26B 76.81M 66.06M 62.13M 56.72M 106M 106M 737M 285M 3.72B 288M 282M 11.85B | 8.41B 88.94M 76.48M 71.94M 65.67M 123M 123M 853M 330M 4.31B 334M 327M 13.72B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
